Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jeffrey R Strich

Showing results (1-10 of 69) with videos related to

Pageof 7
Sort By:
Blood|December 2, 2021
VITT(al) insights into vaccine-related clotsJeffrey R Strich, Yogendra Kanthi
Infectious Disease Clinics of North America|July 9, 2017
Preventing Transmission of Multidrug-Resistant Pathogens in the Intensive Care UnitJeffrey R Strich, Tara N Palmore
Critical Care Medicine|February 22, 2022
Tocilizumab: A Role for Biomarker-Directed Therapy?Jeffrey R Strich, Daniel S Chertow
Annals of Internal Medicine|February 3, 2025
An intensivist-led telemedicine strategy did not reduce ICU LOS vs. usual care in critically ill patientsMorgan K Walker, Jeffrey R Strich,
Annals of Internal Medicine|September 2, 2024
In sepsis, continuous and intermittent infusion of β-lactam antibiotics did not differ for mortality at 90 dMorgan K Walker, Jeffrey R Strich
Seminars in Respiratory and Critical Care Medicine|October 5, 2019
Difficult-to-Treat Antibiotic-Resistant Gram-Negative Pathogens in the Intensive Care Unit: Epidemiology, Outcomes, and TreatmentJeffrey R Strich, Sameer S Kadri
Annals of Internal Medicine|September 2, 2024
In sepsis or septic shock, prolonged vs. intermittent infusion of β-lactam antibiotics reduces mortality at 90 dMorgan K Walker, Jeffrey R Strich
Journal of Clinical Microbiology|November 16, 2018
CRISPR-Cas Biology and Its Application to Infectious DiseasesJeffrey R Strich, Daniel S Chertow
The Journal of Infectious Diseases|July 22, 2020
Considerations for Empiric Antimicrobial Therapy in Sepsis and Septic Shock in an Era of Antimicrobial ResistanceJeffrey R Strich, Emily L Heil, Henry Masur
Critical Care Medicine|March 25, 2020
Sepsis Bundles That Focus on Clinician Judgment and Proven Interventions Are Needed to Increase Bundle Compliance and EffectivenessJeffrey R Strich, Jeffrey Wang, Peter Q Eichacker
Pageof 7

Showing results (1-10 of 69) with videos related to

Sort By:
Pageof 7
Blood|December 2, 2021
VITT(al) insights into vaccine-related clotsJeffrey R Strich, Yogendra Kanthi
Infectious Disease Clinics of North America|July 9, 2017
Preventing Transmission of Multidrug-Resistant Pathogens in the Intensive Care UnitJeffrey R Strich, Tara N Palmore
Critical Care Medicine|February 22, 2022
Tocilizumab: A Role for Biomarker-Directed Therapy?Jeffrey R Strich, Daniel S Chertow
Annals of Internal Medicine|February 3, 2025
An intensivist-led telemedicine strategy did not reduce ICU LOS vs. usual care in critically ill patientsMorgan K Walker, Jeffrey R Strich,
Annals of Internal Medicine|September 2, 2024
In sepsis, continuous and intermittent infusion of β-lactam antibiotics did not differ for mortality at 90 dMorgan K Walker, Jeffrey R Strich
Seminars in Respiratory and Critical Care Medicine|October 5, 2019
Difficult-to-Treat Antibiotic-Resistant Gram-Negative Pathogens in the Intensive Care Unit: Epidemiology, Outcomes, and TreatmentJeffrey R Strich, Sameer S Kadri
Annals of Internal Medicine|September 2, 2024
In sepsis or septic shock, prolonged vs. intermittent infusion of β-lactam antibiotics reduces mortality at 90 dMorgan K Walker, Jeffrey R Strich
Journal of Clinical Microbiology|November 16, 2018
CRISPR-Cas Biology and Its Application to Infectious DiseasesJeffrey R Strich, Daniel S Chertow
The Journal of Infectious Diseases|July 22, 2020
Considerations for Empiric Antimicrobial Therapy in Sepsis and Septic Shock in an Era of Antimicrobial ResistanceJeffrey R Strich, Emily L Heil, Henry Masur
Critical Care Medicine|March 25, 2020
Sepsis Bundles That Focus on Clinician Judgment and Proven Interventions Are Needed to Increase Bundle Compliance and EffectivenessJeffrey R Strich, Jeffrey Wang, Peter Q Eichacker
Pageof 7